The Clinical Feature of Chronic Hepatitis B Patients with High HBV pgRNA
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 1
Abstract
ackground and Aims At present, nucleos(t)ide analogue (NA) is usually used to treat chronic hepatitis B, but there are still some patients with high levels of pgRNA after long-term treatment. We tried to study the clinical characteristics of this part of the population. Methods A total of 211 patients who had been treated with NAs for more than one year and had been followed up in our outpatient department for a long time were included in the study. The concentrations of HBV serological (HBsAg, HBeAg, HBV DNA, anti-HBe) /biochemical indicators (ALT, AST, GGT, AFP) were measured in this study. Results ALT/AST/HBV DNA/HBsAg in high pgRNA group was significantly higher than those in low pgRNA group, and the HBeAg negative rate of high pgRNA group was much lower than that of low pgRNA group. Conclusion CHB patients with high pgRNA are more likely to have relatively active viruses and more severe liver inflammation. In addition, in terms of virological response, the proportion of HBeAg negative in high pgRNA population is significantly higher than that in low pgRNA population, and the titer of HBsAg is significantly higher than that of people with low pgRNA.
Authors and Affiliations
Yunzhe Zhang, Xuezhong Lei
Keywords
Related Articles
- EP ID EP740139
- DOI 10.54457/DR.202301001
- Views 20
- Downloads 0
Clinical Study on Flumatinib Mesylate Combined with Chemotherapy Followed by Autologous Hematopoietic Cell Transplantation in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
Objective To investigate the clinical efficacy and safety of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) patients treated with second-generation tyrosine kinase inhibitor (TKI) flumatinib mesyl...
Bioinformatics Analysis to Screen the Key Genes and Pathways in the Formation of Early T-cell Precursor Acute Lymphoblastic Leukemia
Purpose Early T-cell precursor acute lymphoblastic leukemia (EPT-ALL) is a rare type of ALL that shows genetic characteristics of both ALL and acute myeloid leukemia (AML) but has a poorer prognosis and a higher recurren...
Effect of Comparison between Qingchangligan Granules and Qingchangligan Decoction on D-GalN/LPS-Induced Liver Injury in Mice
Ethnopharmacological relevance The Qingchangligan formula has two dosage forms, granules and decoction. Both of them have the same prescription; however, whether their protective effects are different remain elusive. Ai...
Dendritic Cell Subsets: The Next Target for Pregnant Complications?
Dendritic cells (DCs) are professional antigen-presenting cells with both immune stimulatory and regulatory functions. DCs are critical players in pregnancy, whose dysregulation is associated with multiple pregnancy-rela...
Updating CAR-T Cell Immunotherapy for Liquid and Solid Tumor
According to the GLOBOCAN 2020 report, there is still a 50% mortality rate observed in cancer patients despite the availability of various innovative cancer therapies. This highlights the need for specific therapies that...